大麻二酚减少海洛因使用障碍者线索诱发渴求与焦虑
该探索性双盲随机安慰剂对照试验评估大麻二酚(CBD)对海洛因使用障碍戒断者线索诱发渴求与焦虑的影响。CBD急性给药较安慰剂显著降低药物线索诱发的渴求与焦虑,并在末次3日给药后7天仍有持续效应,同时降低心率与唾液皮质醇,无严重不良反应。
要点
- CBD 400或800 mg每日一次连续3天可急性降低海洛因线索诱发的渴求与焦虑。
- 末次给药后7天仍观察到对渴求与焦虑的持续效应。
- CBD降低线索诱发的心率和唾液皮质醇,未显著影响认知,无严重不良反应。
核心结论
- CBD具有降低海洛因使用障碍戒断者线索诱发渴求与焦虑的潜力,支持进一步研究其作为阿片使用障碍治疗选择。
研究设计与样本
- 探索性双盲随机安慰剂对照试验,纳入海洛因使用障碍戒断个体,CBD 400或800 mg每日一次连续3天。
主要发现
- CBD急性给药较安慰剂显著降低药物线索诱发的渴求与焦虑。
- 末次3日给药后7天,CBD对渴求与焦虑仍显示显著持续效应。
- CBD降低药物线索诱发的心率和唾液皮质醇水平。
- CBD对认知无显著影响,无严重不良反应。
关键数值与推荐
- CBD剂量为400或800 mg,每日一次连续3天。
- 评估时间点包括急性(1小时、2小时、24小时)、短期(连续3天)和持续(末次给药后7天)。
临床怎么用
- 提示CBD可能作为阿片使用障碍的非阿片类辅助治疗选项,但需进一步研究确认。
局限性
- 原文未报告样本量、效应量、置信区间或P值等具体统计数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite the staggering consequences of the opioid epidemic, limited nonopioid medication options have been developed to treat this medical and public health crisis. This study investigated the potential of cannabidiol (CBD), a nonintoxicating phytocannabinoid, to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder. METHODS: This exploratory double-blind randomized placebo-controlled trial assessed the acute (1 hour, 2 hours, and 24 hours), short-term (3 consecutive days), and protracted (7 days after the last of three consecutive daily administrations) effects of CBD administration (400 or 800 mg, once daily for 3 consecutive days) on drug cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder. Secondary measures assessed participants' positive and negative affect, cognition, and physiological status. RESULTS: Acute CBD administration, in contrast to placebo, significantly reduced both craving and anxiety induced by the presentation of salient drug cues compared with neutral cues. CBD also showed significant protracted effects on these measures 7 days after the final short-term (3-day) CBD exposure. In addition, CBD reduced the drug cue-induced physiological measures of heart rate and salivary cortisol levels. There were no significant effects on cognition, and there were no serious adverse effects. CONCLUSIONS: CBD's potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.
引用
- Hurd YL, Spriggs S, Alishayev J, et al. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. Am J Psychiatry. 2019. PMID: 31109198. doi:10.1176/appi.ajp.2019.18101191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。